Company name | Market Cap | Profitability rating | Gross Profit margin (LTM) | EBIT margin (LTM) | EBITDA margin (LTM) | Net Income margin (LTM) | FCF margin (LTM) | Earnings quality (FCF to Net Income) |
$2,336.7M | 6.1 | 50.0% | (1,093,125.0%) | (1,093,062.5%) | (954,300.0%) | (824,137.5%) | 86.4% | |
$124.8B | 6.8 | 86.1% | (2.2%) | 4.4% | (4.9%) | (7.2%) | 147.6% | |
$77.0B | 8.1 | 84.5% | 28.3% | 33.9% | 31.1% | 25.3% | 81.5% | |
$34.4B | 5.9 | 86.8% | (17.1%) | (2.1%) | (4.5%) | (9.4%) | 103.2% | |
$30.7B | 5.3 | 85.6% | (7.9%) | (8.6%) | (12.4%) | (1.9%) | 15.3% | |
$24.0B | 6.3 | 80.3% | (47.8%) | (13.2%) | (24.2%) | (8.4%) | 33.9% | |
$14.5B | 8.4 | 73.9% | 57.1% | 81.0% | 37.9% | 122.3% | 208.1% | |
$13.8B | 9.1 | 89.2% | 47.9% | 55.9% | 41.5% | 37.6% | 90.4% | |
$13.4B | 8.8 | 78.6% | 16.2% | 22.8% | 15.0% | 16.7% | 111.4% | |
$13.3B | 5.7 | N/A | N/A | N/A | N/A | N/A | 64.2% | |
$1,846.9M | 5.8 | 83.7% | (26.3%) | (22.0%) | (95.0%) | (31.4%) | 121.0% |
The Longboard Pharmaceuticals, Inc. (LBPH) gross profit margin is 50.0%, compared to the industry median of 65.7% and the 5-year historical average of 40.6%.
The Longboard Pharmaceuticals, Inc. (LBPH) operating income margin is (954,300.0%), compared to the industry median of (855.0%)) and the 5-year historical average of (792,050.0%).
The Longboard Pharmaceuticals, Inc. (LBPH) Free Cash Flow margin is (824,137.5%), compared to the industry median of (726.1%) and the 5-year historical average of (713,662.5%).
The Longboard Pharmaceuticals, Inc. (LBPH) earnings quality is 86.4%, compared to the industry median of 83.3% and the 5-year historical average of 73.9%.